Atara Biotherapeutics
ATRA
ATRA
37 hedge funds and large institutions have $27M invested in Atara Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.44% less ownership
Funds ownership: 30.25% → 26.81% (-3.4%)
Holders
37
Holding in Top 10
–
Calls
$3K
Puts
–
Top Buyers
| 1 | +$1.05M | |
| 2 | +$592K | |
| 3 | +$316K | |
| 4 |
Morgan Stanley
New York
|
+$301K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$245K |
Top Sellers
| 1 | -$726K | |
| 2 | -$358K | |
| 3 | -$178K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$125K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$31K |
